Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Benboubker
CHRU - Hôpital Bretonneau Tours
Principal Investigator - Brigitte Kolb
Hôpital R. Debré Reims
Principal Investigator - Carine Chaleteix
University Hospital, Clermont-Ferrand
Principal Investigator - Cyril Hulin
Hôpital de Brabois Nancy
Principal Investigator - Denis Caillot
CH DIJON
Principal Investigator - Hervé Maisonneuve
CHD La Roche sur Yon
Principal Investigator - Michel Attal
CHRU - Hôpital Purpan Toulouse
Principal Investigator - Thierry FACON
CHRU - Hôpital Claude Huriez Lille
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu de Nantes
Nantes, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 28 Feb 2014
- Completion
- 28 Feb 2014
- Last update posted
- 13 Apr 2016
- Registered enrollment
- 72
- Registry id
- NCT01279694
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.